✦ LIBER ✦

Disparities in Educational Opportunities and Outcomes: What Do We Know and What Can We Do?

✍ Scribed by Geoffrey Maruyama

Book ID: 110690373
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 126 KB
Volume: 59
Category: Article
ISSN: 0022-4537
DOI: 10.1111/1540-4560.00083

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acetaminophen hepatoxicity: What do we k

Acetaminophen hepatoxicity: What do we know, what don't we know, and what do we do next?

✍ Neil Kaplowitz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Chronic prostatitis: what we know, what

Chronic prostatitis: what we know, what we do not know, and what we should do!

✍ B. Lobel; A. Rodriguez 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 240 KB

: what do we know, and what do we still

: what do we know, and what do we still need to know?

✍ Benjamin D. Levine 📂 Article 📅 2008 🏛 Cambridge University Press 🌐 English ⚖ 413 KB

Public Reporting of Cardiac Surgery Outc

Public Reporting of Cardiac Surgery Outcomes—What Do We Know, What Can We Expect?

✍ David M. Shahian 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

Statins in children: What do we know and

Statins in children: What do we know and what do we need to do?

✍ Donald M. Black 📂 Article 📅 2001 🏛 Current Science Inc. 🌐 English ⚖ 280 KB

Myelin vesicles: What we know and what w

Myelin vesicles: What we know and what we do not know

✍ J. Sedzik; A. E. Blaurock 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 790 KB

## Abstract In the following review, we address difficulties that have arisen when attempting to convert the myelin multilayers into vesicles. The emphasis is on CNS myelin of adult mammals although both central nervous system (CNS) and peripheral nervous system (PNS) myelin are considered. The abi